CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,784,000 | -60.4% | 400,000 | -50.0% | 0.02% | -51.9% |
| Q1 2022 | $27,248,000 | +8.5% | 800,000 | +23.1% | 0.05% | +15.6% |
| Q4 2021 | $25,116,000 | -51.0% | 650,000 | -31.6% | 0.04% | -55.4% |
| Q3 2021 | $51,291,000 | -15.7% | 950,000 | -47.8% | 0.10% | -15.1% |
| Q2 2021 | $60,810,000 | +55.4% | 1,818,478 | -4.3% | 0.12% | +48.8% |
| Q1 2021 | $39,140,000 | -10.6% | 1,900,000 | -24.0% | 0.08% | -15.8% |
| Q4 2020 | $43,800,000 | +44.1% | 2,500,000 | +22.0% | 0.10% | +25.0% |
| Q3 2020 | $30,402,000 | +33.6% | 2,050,000 | +17.1% | 0.08% | +31.0% |
| Q2 2020 | $22,750,000 | – | 1,750,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |